يعرض 1 - 10 نتائج من 211 نتيجة بحث عن '"thyrotoxicosis"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المصدر: Meditsinskiy sovet = Medical Council; № 23 (2023); 202-207 ; Медицинский Совет; № 23 (2023); 202-207 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    العلاقة: https://www.med-sovet.pro/jour/article/view/8019/7111Test; Poorolajal J. The global pandemics are getting more frequent and severe. J Res Health Sci. 2021;21(1):e00502. https://doi.org/10.34172/jrhs.2021.40Test.; Stasiak M, Lewiński A. New aspects in the pathogenesis and management of subacute thyroiditis. Rev Endocr Metab Disord. 2021;22(4):1027–1039. https://doi.org/10.1007/s11154-021-09648-yTest.; Gorini F, Vassalle C. A Literature review on SARS-CoV-2 and other viruses in thyroid disorders: environmental triggers or no-guilty bystanders? Int J Environ Res Public Health. 2023;20(3):2389. https://doi.org/10.3390/ijerph20032389Test.; Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6:5. https://doi.org/10.1186/1743-422X-6-5Test.; Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute thyroiditis after Sars-COV-2 infection. J Clin Endocrinol Metab. 2020;105(7):dgaa276. https://doi.org/10.1210/clinem/dgaa276Test.; Tabassom A, Chippa V, Edens MA. De Quervain Thyroiditis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK526066Test.; Mundy-Baird G, Kyriacou A, Syed AA. De Quervain subacute thyroiditis. CMAJ. 2021;193(26):E1007. https://doi.org/10.1503/cmaj.202787Test.; Martinez Quintero B, Yazbeck C, Sweeney LB. Thyroiditis: Evaluation and Treatment. Am Fam Physician. 2021;104(6):609–617. Available at: https://pubmed.ncbi.nlm.nih.gov/34913664Test.; Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab. 2023;88(5):2100–2105. https://doi.org/10.1210/jc.2002-021799Test.; Alfadda AA, Sallam RM, Elawad GE, Aldhukair H, Alyahya MM. Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol. 2014;794943. https://doi.org/10.1155/2014/794943Test.; Görges J, Ulrich J, Keck C, Müller-Wieland D, Diederich S, Janssen OE. Longterm outcome of subacute thyroiditis. Exp Clin Endocrinol Diabetes. 2020;128(11):703–708. https://doi.org/10.1055/a-0998-8035Test.; Hepşen S, Saat H, Akhanli P, Cakal E. The management of repetitive subacute thyroiditis in a male patient having HLA-B35:01 and B41:02 alleles. Acta Endocrinol (Buchar). 2022;18(4):512–515. https://doi.org/10.4183/aeb.2022.512Test.; Yasuda S, Suzuki S, Yanagisawa S, Morita H, Haisa A, Satomura A et al. HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report. BMC Endocr Disord. 2023;23(1):54. https://doi.org/10.1186/s12902-023-01287-5Test.; Stasiak M, Tymoniuk B, Stasiak B, Lewiński A. The risk of recurrence of subacute thyroiditis is HLA-dependent. Int J Mol Sci. 2019;20(5):1089. https://doi.org/10.3390/ijms20051089Test.; Ray I, D’Souza B, Sarker P, Agarwal P. Management of subacute thyroiditis – a systematic review of current treatment protocols. Int J Gen Med. 2022;15:6425–6439. https://doi.org/10.2147/IJGM.S366784Test.; Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739–741. https://doi.org/10.1016/S2213-8587Test(20)30266-7.; Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020;13(8):e237336. https://doi.org/10.1136/bcr-2020-237336Test.; Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021;44(5):1085–1090. https://doi.org/10.1007/s40618-020-01436-wTest.; Lazarus JH. Silent thyroiditis and subacute thyroiditis. In: Braverman LE, Utiger RD (eds.). The Thyroid: A Fundamental and Clinical Text. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 1996. 577 р.; Тимофеева ЛА, Александров ЮК, Алешина ТН, Юсова МА. Подострый тиреоидит, ассоциированный с COVID-19. Российский электронный журнал лучевой диагностики. 2021;11(3):15–24. https://doi.org/10.21569/2222-7415-2021-11-3-15-24Test.; Chen Y, Zhu S, Chen H, Yao L, Zhou J, Xu Y et al. Diagnostic value of color doppler ultrasonography in subacute thyroiditis. Scanning. 2022:7456622. https://doi.org/10.1155/2022/7456622Test.; Cappelli C, Pirola I, Gandossi E, Formenti AM, Agosti B, Castellano M. Ultrasound findings of subacute thyroiditis: a single institution retrospective review. Acta Radiol. 2014;55(4):429–433. https://doi.org/10.1177/0284185113498721Test.; Lee YJ, Kim DW. Sonographic characteristics and interval changes of subacute thyroiditis. J Ultrasound Med. 2016;35(8):1653–1659. https://doi.org/10.7863/ultra.15.09049Test.; Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646–2655. https://doi.org/10.1056/NEJMra021194Test.; Aemaz Ur Rehman M, Farooq H, Ali MM, Ebaad Ur Rehman M, Dar QA, Hussain A. The association of subacute thyroiditis with COVID-19: a systematic review. SN Compr Clin Med. 2021;3(7):1515–1527. https://doi.org/10.1007/s42399-021-00912-5Test.; Christensen J, O’Callaghan K, Sinclair H, Hawke K, Love A, Hajkowicz K, Stewart AG. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Int Med J. 2022;52(4):522–529. https://doi.org/10.1111/imj.15432Test.; Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino Ch, Hasell J et al. Coronavirus Pandemic (COVID-19). 2020.; Wijenayake UN, Ratnayake GM, Abeyratne D, Bulugahapitiya US. A case report of subacute thyroiditis after inactivated SARS-CoV-2 vaccine. SAGE Open Med Case Rep. 2022;10:2050313X221140243. https://doi.org/10.1177/2050313X221140243Test.; Plaza-Enriquez L, Khatiwada P, Sanchez-Valenzuela M, Sikha A. A case report of subacute thyroiditis following mRNA COVID-19 vaccine. Case Rep Endocrinol. 2021:8952048. https://doi.org/10.1155/2021/8952048Test.; Adelmeyer J, Goebel JN, Kauka A, Kann PH. Two case reports of subacute thyroiditis after receiving vaccine for COVID-19. Case Rep Endocrinol. 2022:2022:3180004. https://doi.org/10.1155/2022/3180004Test.; Frangos S, Haralambous H, Michael K, Economides PA. Subacute thyroiditis after the third dose of the COVID-19 mRNA vaccine. Case report. Hell J Nucl Med. 2022:25(2):210–212. https://doi.org/10.1967/s002449912481Test.; Cohen Tervaert JW, Martinez-Lavin M, Jara LJ, Halpert G, Watad A, Amital H, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023. Autoimmun Rev. 2023;22(5):103287. https://doi.org/10.1016/j.autrev.2023.103287Test.; Pulendran B, Arunachalam PS, O’Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021;20(6):454–475. https://doi.org/10.1038/s41573-021-00163-yTest.; Facciolà A, Visalli G, Laganà A, Di Pietro A. An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines (Basel). 2022;10(5):819. https://doi.org/10.3390/vaccines10050819Test.; Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480. https://doi.org/10.1016/j.clim.2020.108480Test.; Pipitone G, Rindi LV, Petrosillo N, Foti NAM, Caci G, Iaria C et al. Vaccine-induced subacute thyroiditis (De Quervain’s) after mRNA vaccine against SARS-CoV-2: a case report and systematic review. Infect Dis Rep. 2022;14(1):142–154. https://doi.org/10.3390/idr14010018Test.; Oğuz SH, Şendur SN, İremli BG, Gürlek A, Erbas T, Ünlütürk U. SARS-CoV-2 vaccine-induced thyroiditis: safety of revaccinations and clinical follow-up. J Clin Endocrinol Metab. 2022;107(5):e1823–e1834. https://doi.org/10.1210/Clinem/dgac049Test.; Bahçecioğlu AB, Karahan ZC, Aydoğan BI, Kalkan IA, Azap A, Erdoğan MF. Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J Endocrinol Invest. 2022;45(4):865–874. https://doi.org/10.1007/s40618021-01718-xTest.; Sarker R, Roknuzzaman ASM, Nazmunnahar Hossain MJ, Islam MR. Benefits and probable ill effects of WHO’s declaration of end of COVID-19 pandemic: a way back to pandemic-free normal life. Ann Med Surg (Lond). 2023;85(6):3199–3201. https://doi.org/10.1097/MS9.0000000000000848Test.; https://www.med-sovet.pro/jour/article/view/8019Test

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية